Pharma Journalist -

AbbVie and I-Mab announced that AbbVie and I-Mab have signed a broad, global collaboration agreement for the development and commercialization of lemzoparlimab (also known as TJC4), an…
Read More...

Ehave, Inc. a provider of digital therapeutics delivering evidence-based therapeutic interventions to patients, announced it is entering into a licensing agreement with a telemedicine…
Read More...

PPD, Inc. and Lupus Therapeutics (LT), an affiliate of the Lupus Research Alliance known for its lupus clinical trials expertise, have entered into a collaboration to expand and enhance…
Read More...

On 2 September, WHO published guidance for clinicians and health care decision-makers on the use of corticosteroids in patients with COVID-19. We recommend systemic corticosteroids…
Read More...

Sanofi and GSK announce the start of the Phase 1/2 clinical trial for their adjuvanted COVID-19 vaccine. The vaccine candidate, developed in partnership by Sanofi and GSK, uses the same…
Read More...

Kite, a Gilead Company, and HiFiBiO Therapeutics announced the companies have entered into a two-year research collaboration and license agreement in acute myeloid leukemia (AML).…
Read More...

Enesi Pharma, an innovative biotechnology company developing next-generation vaccination products targeting serious diseases, is delighted to announce its partnership with the…
Read More...

The U.S. Food and Drug Administration (FDA) approved two additional doses of Eli Lilly and Company's Trulicity (dulaglutide). The approval expands the label of once-weekly Trulicity to…
Read More...

SMi Reports: Registration is open for SMi Group’s 13th annual conference and exhibition taking place in January 2021. The pre-filled syringes industry is growing at an exponential…
Read More...

Santhera Pharmaceuticals announces that it has signed agreements with Idorsia and ReveraGen BioPharma Inc., making Santhera a direct license holder of vamorolone. Under the agreements,…
Read More...